Effects of a phyisiotherapeutic exercise programme in patients with a combination of COPD and chronic heart failure: the CHEST-study.
- Conditions
- Chronic heart failure and COPD.
- Registration Number
- NL-OMON26228
- Lead Sponsor
- Department of Pulmonary Medicine, Medisch Spectrum Twente Enschede
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Age between 40 and 75 years;
2. A clinical diagnosis of COPD defined by the GOLD-criteria stage 2 and 3;
Exclusion Criteria
1. Serious other diseases with a survival rate of less than 1 year;
2. Other diseases which generate symptoms of dyspnoea and/or decreased
exercise capacity, or which seriously influence the ability to walk;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is exercise capacity measured with the 6 Minutes Walking Test, and daily activity rate, measured by pedometer.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are:<br /><br>1. Health-related quality of life (disease specific: Clinical COPD Questionnaire, Minnesota Living with Heart Failure Questionnaire, and generic: Euroqol 5D, SF-36);<br /><br>2. Health-related behaviour (European Heart Failure Self-care Behaviour Scale);<br /><br>3. Self-efficacy (COPD Self-efficacy scale);<br /><br>4. Exercise capacity measured with the Incremental Shuttle Walk Test.